Meeting
2022 ASCO Annual Meeting
Identification of super-exhausted T cells: A novel population predictive of response to immunotherapy.
Authors
Florent Peyraud
Institut Bergonié, Bordeaux, France
Florent Peyraud , Jean-Philippe Guegan , Christophe Rey , Sophie Cousin , Guilhem Roubaud , Mathilde Cabart , Maxime Brunet , Ezogelin Oflazoglu Gruyters , Ariel Savina , Sylvestre Le Moulec , Bérangère Dadone-Montaudon , Fabrice Barlesi , Benjamin Besse , Yohann Loriot , Aurelien Marabelle , Jean-Charles Soria , Jean-Yves Scoazec , François Le Loarer , Alban Bessede , Antoine Italiano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
PD1/PD-L1 Inhibitor Monotherapy
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2596)
DOI
10.1200/JCO.2022.40.16_suppl.2596
Abstract #
2596
Poster Bd #
251
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2021 ASCO Annual Meeting
NCT04552223: A phase II study of nivolumab plus BMS-986016 (relatlimab) in patients with metastatic uveal melanoma (UM) (CA224-094).
First Author: Jose Lutzky
Poster
2019 Gastrointestinal Cancers Symposium
Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.
First Author: Hirofumi Ohmura
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri